Moreover, they generated two synthetic ligands that selectively inhibit TGF-β-SMAD signal transduction without activating vitamin D receptor (VDR)-mediated transcription or causing hypercalcemia [35]. The gene discussed is VDR; the disease is hypercalcemia disease.